A randomised, controlled trial of the psychological effects of reflexology in early breast cancer

European Journal of Cancer

Volumn 46, Issue 2, 2010, Pages 312-322

  Sharp, Donald M ^a,b,c   Walker, Mary B ^a,c   Chaturvedi, Amulya ^c   Upadhyay, Sunil ^c   Hamid, Abdel ^c   Walker, Andrew A ^a,c   Bateman, Julie S ^c   Braid, Fiona ^c   Ellwood, Karen ^c   Hebblewhite, Claire ^c   Hope, Teresa ^c   Lines, Michael ^c   Walker, Leslie G ^a,b,c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Early breast cancer; Mood; Quality of life; Reflexology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASSAGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REFLEXOLOGY; SELF CARE; SELF INITIATED SUPPORT; TREATMENT OUTCOME;

ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; BREAST NEOPLASMS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MASSAGE; MENTAL HEALTH; MIDDLE AGED; PATIENT COMPLIANCE; POSTOPERATIVE CARE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 72449140632     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.10.006     Document Type: Article

References (45)

1. Hall A., A'Hern R., and Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?. Eur J Cancer 35 (1999) 79-85
2. Burgess C., Cornelius V., Love S., et al. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ (2005) 10.1136/bmj.38343.670868.D3 [published 4 February 2005]
3. Baum M., Ernst E., Lejeune S., and Horneber M. Role of complementary and alternative medicine in the care of patients with breast cancer: report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004. Eur J Cancer 42 (2006) 1702-1710
4. Ernst E., and Cassileth B.R. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83 (1998) 777-782
5. Maher E.J., Young T., and Feigel I. Complementary therapies used by cancer patients. Br Med J 309 (1994) 671-672
6. Downer S.M., Cody M.M., McCluskey P., et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 309 (1994) 86-89
7. Gerber B., Scolz C., Reimer T., et al. Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 95 (2006) 199-209
8. Buettner C., Kroenke C.H., Phillips R.S., et al. Correlates of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat 100 (2006) 219-227
9. Dougans I. The complete illustrated guide to reflexology (1996), Element Books, Shaftsbury
10. Norman L. The reflexology handbook; a complete guide (1988), The Bath Press, Bath
11. Sharma U. Complementary medicine today (1992), Routledge, New York
12. Wills P. The reflexology manual (1995), Headline Book Publishing, London
13. Corner J, Harewood J, Maslin-Prothero S. A study of the use of complementary and alternative therapies among people undergoing cancer treatment: a quantitative and qualitative study. NHS R&D Programme. London: Department of Health, HMSO; 2006.
14. Oleson T., and Flocco W. Randomised controlled study of pre-menstrual symptoms treated with ear, hand and foot reflexology. Obstet Gynecol 82 (1993) 906-911
15. Wang X.M. Treating type II diabetes mellitus with foot reflexotherapy. Chung-Kuo Chung His I Chieh Ho Tsa Chih 13 (1993) 536-538
16. Kovacs F.M., Abraira V., Lopez-Abente G., and Pozo F. Neuro-reflexotherapy intervention in the treatment of non-specific low back pain: a randomised, controlled, double blind clinical trial. Med Clin 101 (1993) 570-575
17. Quattrin R., Zanini A., and Buchini S. Use of reflexology and foot massage to reduce anxiety in hospitalized cancer patients: methodology and outcomes. J Nurs Manag 14 (2006) 96-105
18. Benson H. The relaxation response (2000), Harpertorch, New York
19. Walker L.G., Walker M.B., Heys S.D., et al. The psychological, clinical and pathological effects of relaxation training and imagery during primary chemotherapy. Br J Cancer 80 (1999) 262-268
20. Frank J.D., and Frank J.B. Persuasion and healing: a comparative study of psychotherapy (1991), John Hopkins University Press, Baltimore
21. House of Commons Health Committee. Palliative Care Memorandum by Hull and East Yorkshire Hospitals NHS Trust (PC 19); 2004.
22. Walker L.G., Walker M.B., and Sharp D.M. The organisation of psychosocial support within palliative care. In: Lloyd-Williams M. (Ed). Psychosocial issues in palliative care (2003), Oxford University Press, Oxford
23. Walker L.G., Walker M.B., and Sharp D.M. Psychosocial oncology services for women with breast cancer. Update Urol Gynaecol Sex Health 8 (2003) 25-32
24. Walker A.A., Walker M.B., Walker L.G., and Sharp D.M. What happens to anxiety and depression in women with early breast cancer accessing an integrated Oncology Health Service?. Psychooncology 15 (2006) S452
25. Walker L.G., Walker M.B., Anderson J., et al. Is quality of life better during primary CVAP or docetaxel chemotherapy?. Psychooncology 8 (1999) 12
26. Walker L.G., Eremin J.M., Vassanasiri W., et al. Quality of life during three-weekly versus weekly neoadjuvant docetaxel: a randomised trial. Psychooncology 15 (2006) S451
27. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 11 (1993) 70-579
28. Brady M.J., Cella D.F., Mo F., et al. Reliability and validity of the Functional Assessment of Cancer Therapy - Breast Quality of Life Instrument. J Clin Oncol 15 (1997) 974-986
29. Fallowfield L., Cella D., Cuzick J., et al. Quality of life of postmenopausal women in the arimadex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 21 (2004) 4261-4271
30. Anderson J., Walker M.B., Swanson V., and Walker L.G. The Mood Rating Scale: a brief, acceptable, reliable and valid state measure of normal mood. Psychooncology 9 (2000) 359
31. Johnson V.C., Walker L.G., Whiting P.H., et al. Can relaxation training and hypnotherapy modify the immune response to acute stress, and is hypnotisability relevant?. Contemp Hypnosis 13 (1996) 100-108
32. Walker L.G., Walker M.B., Heys S.D., et al. The psychological and psychiatric effects of rIL-2: a controlled clinical trial. Psychooncology 6 (1997) 290-301
33. Wesnes K.A., Walker M.B., Heys S.D., et al. What does a weekend 'on call' in a surgical ward do to cognitive performance and mood?. Br J Surg 84 (1997) 493-495
34. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
35. Hermann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 42 (1997) 17-41
36. Hopwood P., Howell A., and Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 64 (1991) 353-356
37. Ibbotson T., Maguire P., Selby P., et al. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 33A (1994) 37-40
38. Razavi D., Delvaux N., Farvacques C., and Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiat 156 (1990) 79-83
39. APA. Diagnostic and statistical manual of mental disorders (DSM-IV-TR) (2000), American Psychiatric Association, Washington
40. Elashoff J.D. nQuery advisor user's guide (2000), Dixon Associates, Los Angeles, CA
41. Vickers A.J., and Altman D.G. Statistics notes: analysing controlled trials with baseline and follow up measurements. Br Med J 10 323 (2001) 1123-1124
42. Eton D.T., Cella D., Yost K.J., et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 57 (2004) 898-910
43. Corner J., Cawley N., and Hildebrand S. An evaluation of the use of massage and essential oils on the wellbeing of cancer patientgs. Int J Paliat Nurs 1 (1995) 67-73
44. Fellowes D, Barnes K, Wilkinson S. Aromatherapy and massage for symptom relief in patients with cancer. The Cochrane Collaboration. John Wiley and Sons; 2006.
45. Wilkinson S.M., Love S.B., Westcombe A.M., et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicentre randomised controlled trial. J Clin Oncol 25 (2007) 532-539